title: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.
authors.affiliation: Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Siegel
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: P
authors.initials: P
authors.lastname: Richardson
authors.affiliation: Department of Clinical Therapeutics, University of Athens, Athens, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Dimopoulos
authors.affiliation: University Hospital, Nantes, France.
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.affiliation: Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
authors.forename: C
authors.initials: C
authors.lastname: Mitsiades
authors.affiliation: MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: D
authors.initials: D
authors.lastname: Weber
authors.affiliation: Merck & Co. Inc., Whitehouse Station, NJ, USA.
authors.forename: J
authors.initials: J
authors.lastname: Houp
authors.affiliation: Merck & Co. Inc., Whitehouse Station, NJ, USA.
authors.forename: C
authors.initials: C
authors.lastname: Gause
authors.affiliation: Merck & Co. Inc., Whitehouse Station, NJ, USA.
authors.forename: S
authors.initials: S
authors.lastname: Vuocolo
authors.affiliation: Merck & Co. Inc., Whitehouse Station, NJ, USA.
authors.forename: J
authors.initials: J
authors.lastname: Eid
authors.affiliation: Pharmacyclics Inc., Sunnyvale, CA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Graef
authors.affiliation: Department of Medicine, Harvard Medical School and Kraft Family Blood Center, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: K C
authors.initials: KC
authors.lastname: Anderson